TCM
ARA

TimesSquare Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

TimesSquare Capital Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-955,431
Closed -$5.87M – 240
2019
Q1 		$5.87M Buy
955,431
+98,200
+11% +$1.14M 0.05% 208
2018
Q4 		$9.88M Sell
857,231
-125,189
-13% -$2.14M 0.09% 202
2018
Q3 		$21.3M Buy
982,420
+198,920
+25% +$3.76M 0.14% 195
2018
Q2 		$12.4M Sell
783,500
-16,500
-2% -$259K 0.08% 220
2018
Q1 		$15.1M Sell
800,000
-253,100
-24% -$4.99M 0.1% 208
2017
Q4 		$18.3M Sell
1,053,100
-77,200
-7% -$1.07M 0.12% 212
2017
Q3 		$16.9M Sell
1,130,300
-159,900
-12% -$2.51M 0.11% 213
2017
Q2 		$23.9M Buy
1,290,200
+80,650
+7% +$1.4M 0.15% 202
2017
Q1 		$20.4M Buy
1,209,550
+41,500
+4% +$828K 0.13% 211
2016
Q4 		$24.9M Sell
1,168,050
-22,400
-2% -$460K 0.17% 198
2016
Q3 		$21.8M Buy
1,190,450
+130,450
+12% +$2.94M 0.14% 204
2016
Q2 		$30.7M Buy
+1,060,000
New +$29.5M 0.2% 171

Other funds holding ARA

CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TimesSquare Capital Management's ARA Position: Q2 2019 in Review

TimesSquare Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2019, closing a stake of 955,431 shares — an estimated $5.87M sold.

TimesSquare Capital Management first reported a position in ARA in Q2 2016 and held it in 12 quarters. The position peaked at $30.7M in Q2 2016. 67 funds tracked by Wall St. Rank hold ARA as of Q2 2019.

  • TimesSquare Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q2 2019 after selling out during the quarter.
  • TimesSquare Capital Management sold 955,431 American Renal Associates Holdings, Inc shares in Q2 2019, an estimated $5.87M.
  • TimesSquare Capital Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 12 quarters.
  • TimesSquare Capital Management's American Renal Associates Holdings, Inc position peaked at $30.7M in Q2 2016.
  • 67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2019.

Based on TimesSquare Capital Management's 13F filing for Q2 2019, filed 2 Aug 2019.